AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$567M |
| 2 |
Visa
V
|
+$283M |
| 3 |
CVS Health
CVS
|
+$195M |
| 4 |
Texas Instruments
TXN
|
+$188M |
| 5 |
Progressive
PGR
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$274M |
| 2 |
Microsoft
MSFT
|
+$263M |
| 3 |
Comcast
CMCSA
|
+$248M |
| 4 |
Amphenol
APH
|
+$238M |
| 5 |
Elevance Health
ELV
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.59% |
| 2 | Financials | 14.66% |
| 3 | Healthcare | 14.25% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDCO
501
DELISTED
Medicines Co
MDCO
| $41.2M | 0.03% |
1,092,990
-4,355
| -0.4% | -$164K |
|
502
International Paper
IP
$20.1B
| $40.8M | 0.03% |
898,915
+39,947
| +5% | +$1.76M |
|
503
Nutanix
NTNX
$14.2B
| $40.7M | 0.03% |
+1,100,000
| New | +$40.7M |
|
504
Vertex Pharmaceuticals
VRTX
$120B
| $40.6M | 0.03% |
466,049
+1,358
| +0.3% | +$128K |
|
505
Royal Bank of Canada
RY
$290B
| $40.6M | 0.03% |
654,880
-50,276
| -7% | -$3.09M |
|
506
Advanced Energy
AEIS
$12.6B
| $40.4M | 0.03% |
853,587
+739,678
| +649% | +$31.4M |
|
507
HCA Healthcare
HCA
$83.5B
| $40.3M | 0.03% |
533,314
-5,895
| -1% | -$451K |
|
|
GRFS
508
Grifois
GRFS
$5.13B
| $40.1M | 0.03% |
2,513,463
+112,827
| +5% | +$1.86M |
|
|
ARIA
509
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $40.1M | 0.03% |
2,930,036
+2,453,451
| +515% | +$24.6M |
|
510
Trane Technologies
TT
$106B
| $40.1M | 0.03% |
589,602
+128,352
| +28% | +$8.55M |
|
511
Clorox
CLX
$11.3B
| $40M | 0.03% |
319,358
-69,059
| -18% | -$9.05M |
|
512
Cummins
CMI
$91.8B
| $40M | 0.03% |
311,921
+13,767
| +5% | +$1.67M |
|
|
STJ
513
DELISTED
St Jude Medical
STJ
| $39.6M | 0.03% |
496,593
+710
| +0.1% | +$57.3K |
|
514
Western Alliance Bancorporation
WAL
$9.06B
| $39.6M | 0.03% |
1,054,717
+56,292
| +6% | +$2M |
|
515
D.R. Horton
DHI
$39.9B
| $39.3M | 0.03% |
1,301,949
-177,094
| -12% | -$5.68M |
|
|
BHI
516
DELISTED
Baker Hughes
BHI
| $39.2M | 0.03% |
777,667
-5,320
| -0.7% | -$256K |
|
517
Marathon Petroleum
MPC
$91.2B
| $39.1M | 0.03% |
964,085
-3,580
| -0.4% | -$145K |
|
518
HF Sinclair
DINO
$16.1B
| $39.1M | 0.03% |
1,596,513
-19,572
| -1% | -$492K |
|
|
INFN
519
DELISTED
Infinera Corporation Common Stock
INFN
| $38.8M | 0.03% |
4,295,194
+119,067
| +3% | +$1.15M |
|
520
Marriott International
MAR
$96.1B
| $38.7M | 0.03% |
575,110
+227,516
| +65% | +$16M |
|
521
State Street SPDR S&P Dividend ETF
SDY
$21.6B
| $38.6M | 0.03% |
457,904
+47,370
| +12% | +$4.04M |
|
522
Republic Services
RSG
$66.9B
| $38.5M | 0.03% |
762,367
+53,014
| +7% | +$2.72M |
|
523
NNN REIT
NNN
$9.25B
| $38.2M | 0.03% |
751,951
-1,445
| -0.2% | -$73.8K |
|
|
QVCGA
524
DELISTED
QVC Group Inc Series A
QVCGA
| $38.2M | 0.03% |
39,319
-45,478
| -54% | -$50.1M |
|
525
Digital Realty Trust
DLR
$66.4B
| $37.7M | 0.03% |
387,700
+2,836
| +0.7% | +$289K |
|
Similar funds
AllianceBernstein's Q3 2016 Portfolio in Review
As of Q3 2016, AllianceBernstein held 3,058 positions worth $118B, up 2% from $116B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AllianceBernstein's Q3 2016 filing shows 95 new, 1,049 increased, 1,331 reduced and 82 closed positions. Its largest new stake was Teva Pharmaceuticals: 2,294,681 shares worth $106M. The largest sale was Pfizer, an estimated $274M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- AllianceBernstein's largest Q3 2016 buy was Teva Pharmaceuticals: 2,294,681 shares worth $106M.
- AllianceBernstein added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $567M increase.
- AllianceBernstein's biggest Q3 2016 reduction was Pfizer, cutting an estimated $274M.
- AllianceBernstein fully exited EMC CORPORATION in Q3 2016, selling an estimated $99.6M.
- AllianceBernstein's ten largest holdings make up 14% of its $118B portfolio in Q3 2016.
- AllianceBernstein opened 95 new positions and closed 82 in Q3 2016.
- AllianceBernstein's portfolio value rose 2% quarter-over-quarter to $118B.
Based on AllianceBernstein's 13F filing for Q3 2016, filed 10 Nov 2016.